[1] 钟南山.支气管哮喘—基础与临床[M]. 北京:人民卫生出版社,2006:221-223.
[2] 马超,任少敏.白介素与支气管哮喘的关系研究进展[J]. 中国民族民间医药,2010,20(5):25-26.
[3] OCHI H,HIRANI WM,YUAN Q,et al. T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro[J]. Exp Med,1999,190(2):267-280.
[4] DEO SS, MISTRY KJ, KAKADE AM, et al. Role played by Th2 type cytokines in IgE mediated allergy and asthma[J]. Lung INDIA,2010,27:66-71.
[5] 王震,梅晓冬.白介素-4与支气管哮喘的相关性研究[J]. 国际老年医学杂志,2011,32(3):135-138.
[6] 杨学敏,史孩广,成家军,等.白介素4在支气管哮喘发病机制中的作用及其靶向治疗研究[J]. 中华哮喘杂志,2011,5(2):112-116.
[7] TAKATSU K, NAKAJIMA H. IL-5 and eosinophilia[J]. Curr 0pin Immuno,2008,20(3):288-294.
[8] LAMPINEN M. CARLSON M. HAKANSSON LD, et al. Cytokine regulated accumulation of eosinophils in inflammatory disease[J]. Allergy,2004,59:793-805.
[9] LEE JJ, ROSENBERG HF. Eosinophils in health and disease[M]. Access Online via Elsevier,2012.
[10] 熊瑛,李国平,扬礼腾,等.白介素5与转录激活因子和信号转导子1表达水平及其信号转导对支气管哮喘豚鼠气道炎症影响的研究[J]. 中华哮喘杂志,2008,2(1):41-45.
[11] HOGAN SP, MOULD AW, YOUNG JM, et al. Cellular and molecular regulation of eosinophil trafficking to the lung. Immunol Cell Bi0l[J]. 1998,76(5):454-460.
[12] KUMAR RK, HERBERT C, WEBB DC, et al. Effects of anticytokine therapy in a mouse model of chronic asthmatic[J]. Am J Respir Crit Care Med.2004,170(10):1043-1048.
[13] 张小容.细胞因子在支气管哮喘中的作用[J]. 甘肃中医学院学报,2009,26(4):48-51.
[14] KADOWAKI N. Dendritic cells:a conductor of T cell differentiation[J]. Allergol Int,2007,56:193-199.
[15] HATTORI K, NISHIKAWA M, Watcharanurak K.et al. Sustained exogenous expression of therapeutic levels of IFN-gamma ameliorates atopic dermatitis in NC/Nga mice via Thl polarization[J]. J Immuno,2010,184:2729-2735.
[16] 饶兴愉,陈强.白介素基因多肽性与支气管哮喘研究现状[J]. 中国全科医学,2007,(14):1209-1211.
[17] 贺明,杨建民,张静.祛瘀化痰法对哮喘大鼠血管内皮细胞黏附分子及白介素12表达的影响[J]. 中国实用医药,2009,4(9):3-4.
[18] 马雨霞,刘晓民,焦桂微. 白介素12基因多态性和支气管哮喘的相关性研究[J]. 中华哮喘杂志,2010,4(5):329-333.
[19] LEONARD P, SUR S. Interleukin-12: potential role in asthma therapy[J]. Bio Drugs,2003,17:1-7.
[20] 范新蕾,田锋,田洪德.白介素与支气管哮喘相关关系的研究进展[J]. 临沂医学专科学校学报,2005,27(1):45-47.
[21] 徐勤枝,丁新明,李强,等.IL-13与支气管哮喘[J]. 国外医学(免疫学分册),2001,24(3):156.
[22] CHO SJ, KANG MJ, HOMER RJ, et al. Role of early growth response-1(Egr-1) in interleukin-13-induced inflammation and remodeling[J]. J Biol Chem,2006,281:8161-8168.
[23] 王鹤翔,刘建秋.白介素13在支气管哮喘发病中的作用[J]. 黑龙江医学,2014,38(8):933-934.
[24] DAVID M, WALTER JJ, MCINTIRE GB, et al. Critical role of IL-13 in the development of allergen-induced airway hyperreactivity[J]. Immunol,2001,167(8):4668-4675.
[25] 李飞,刘剑波. 干扰素在支气管哮喘中的免疫学作用[J]. 中华哮喘杂志,2009,3(2):146-148.
[26]李飞,刘剑波.干扰素 对支气管哮喘小鼠气道杯状细胞化生及其分泌黏蛋白Muc5ac的影响[J]. 中华结核和呼吸杂志,2008,31(7):534-535.
[27] 黄飞燕. HLA-DQA1基因多态性与儿童支气管哮喘的相关性及血清IL-4, IFN-水平关系的研究[D]. 沪州:沪州医学院,2013:23-31.
[28] LI-WEBER M, KRAMMER PH. Regulation of IL4 gene expression by T cells and therapeutic perspectives[J].Nat Rev Immunol,2003,3(7):534-543.
[29] PECARIC-PETKOVIC T, DIDICHENKO SA,KAEMP-FER S, et al. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33[J]. Blood,2009,113(7):1526-1534.
[30] IL-33, IL-15, IL-4及IFN- 在小儿支气管哮喘发病中的作用[D].河北:河北医科大学,2013:28-33.
[31] 姚一楠,李和权,曹婕低剂量IFN-γ诱导哮喘小鼠气道CD4+T细胞FAS/FASL表达水平的恢复[A]. 中华医学会呼吸病学年会-2011(第十二次全国呼吸病学学术会议)论文汇编[C]. 2011:543-545.
[32] OH JW, LEE HB, KIM CR, et al. Analysis of induced sputum to examine the effects of inhaled corticosteroid on airway inflammation in children with asthma[J].Ann Allergy Asthma Immunol,1999,82:491-496.
[33] COXON A, TANG T, MAYADAS TN. Cytokine-activated endothelial cells delay neutrophil apoptosis in vitro and in vivo:a role for granulocyte/macrophage colony-stimulating factor[J]. J EXP Med,1999,190(7):923-934.
[34] MUESSEL MJ, SCOTT KS, FRIEDL P, et al. CCL11 and GM-CSF differentially use the Rho GTPase pathway to regulate motility of human eosinophils in a three-dimensional microenvironment[J].J Immunol,2008,180:8354-8360.
[35] FAITH A, FERNANDEZ MH, CAULFIELD J, et al. Role of cysteinyl leukotrienes in human allergen-specific Th2 responses induced by granulocyte macrophage-colony stimulating factor[J]. Allergy,2008,63:168-175.
[36] 柳萍,周新.粒细胞-巨噬细胞集落刺激因子与支气管哮喘的研究进展[J]. 中华哮喘杂志,2010,4(1):56-59.
[37] OETTGEN HC. Mast cells and tumour necrosis factor alpha(TNF-α):partners in crime in asthma pathogenesis[J]. Clin Immunol,2011,140(1):1-2.
[38] 方丽萍,赵明,张鹏鹏,等.难治性哮喘患者血清肿瘤坏死因于-α的表达及其与肺功能和气道炎症的关系[J]. 医学研究生学报,2014,27(1):55-57.
[39] 刘静静,谭薇,丁召磊.哮喘小鼠模型肺组织、肺泡灌洗液中TNF-α、及IL-12水平比较[J].潍坊医学院学报,2014,36(2):120-122.
[40] BRIGHTLING C, BERRY M, AMRANI Y, et al. Targeting TNF-α:A novel therapeutic approach for asthma.Allergy[J]. Clin Immunol,2008,121(1):5-10.
[41] SADIK CD, KIMND, LUSTER AD. Neutrophils cascading their way to intlamrnation[J]. Trends Immunol,2011,32(10):452-460.
[42] 张如峰,杨挂文,安利国.趋化因子及其受体在炎症中作用的研究进展[J]. 国际免疫性杂志,2012,35(3):64-66.
[43] YON VIETINGHOFF S, ASAGID M, AZAR D, et al. Defective regulation of CXER2 facilitates neutrophil release from bone marrow causing spontaneous inflammation in severely NF-kappa B-deficient mice[J].Lmmunol,2010,185(1):670-678.
[44] 岳欢,李燕,高婧,等.基因芯片对哮喘小鼠趋化因子及其受体差异表达的筛选与分析[J]. 遵义医学院学报,2014,37(3):286-289.
[45] 郑吉善,李昌崇.胸腺和活化调节趋化因子与支气管哮喘[J]. 国际呼吸杂志,2006,26(1):31-34.
[46] 薛涛,张艳荣.沙美特罗替卡松粉吸入剂联合孟鲁司特对支气管哮喘患儿细胞免疫及血清瘦素、嗜酸性粒细胞趋化因子、ECP、LPO的影响[J]. 中国医药导报,2013,10(34):82-84.
[47] 李燕,郭宇,史小玲,等.HSP70/CD80 DNA疫苗通过调节趋化因子及受体对哮喘小鼠气道炎症的影响[J]. 中华微生物学和免疫学杂志,2013,33(2):123-128.
[48] KOIDAS, TSUKASAKI K, TSUCHIYA T, et al. Primary T-cell lymphoma of the thyroid gland with chemokine receptors of Th1 phenotype complicating autoimmune thyroiditis[J]. Haematologica,2007,92(3):e37-e40.
[49] 周艳秋,田颖,秦芳,等.巨噬细胞衍生趋化因子启动区内基因多态性和支气管哮喘的相关性研究[J]. 中国医师杂志,2014,16(1):37-41. |
